Resistance to Ceftriaxone and Azithromycin in Neisseria gonorrhoeae Isolates From 7 Countries of South America and the Caribbean: 2010–2011

Simple item page
dc.contributor.authorSidharath Dev Thakur
dc.contributor.authorPamela Araya
dc.contributor.authorGraciela Borthagaray
dc.contributor.authorPatricia Galarza
dc.contributor.authorAlina Llop Hernández
dc.contributor.authorDaisy Payares
dc.contributor.authorOlga Marina Sanabria Cruz
dc.contributor.authorMarıa Elena Trigoso Carvallo
dc.contributor.authorAura Helena Corredor
dc.contributor.authorJo‐Anne R. Dillon
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T14:35:23Z
dc.date.available2026-03-22T14:35:23Z
dc.date.issued2017
dc.descriptionCitaciones: 21
dc.description.abstractSeven countries in Latin America and the Caribbean report on (2010 and 2011) the susceptibility of 2235 isolates of Neisseria gonorrhoeae to 6 antibiotics. Thirteen isolates had ceftriaxone minimum inhibitory concentrations (MICs) of 0.125 to ≥ 0.25 mg/L. The percentage of resistant isolates to the following antibiotics was: azithromycin, 1.0% to 1.7%; ciprofloxacin, 42.1% to 36.2%; penicillin, 31% to 35%; tetracycline, 21.8% to 22.6%.
dc.identifier.doi10.1097/olq.0000000000000587
dc.identifier.urihttps://doi.org/10.1097/olq.0000000000000587
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/47392
dc.language.isoen
dc.publisherLippincott Williams & Wilkins
dc.relation.ispartofSexually Transmitted Diseases
dc.sourceUniversity of Saskatchewan
dc.subjectNeisseria gonorrhoeae
dc.subjectCeftriaxone
dc.subjectMedicine
dc.subjectAzithromycin
dc.subjectMicrobiology
dc.subjectGonorrhea
dc.subjectNeisseriaceae
dc.subjectNeisseria
dc.subjectSexually transmitted disease
dc.subjectVirology
dc.titleResistance to Ceftriaxone and Azithromycin in Neisseria gonorrhoeae Isolates From 7 Countries of South America and the Caribbean: 2010–2011
dc.typearticle

Files

Collections

Artículo Científico Publicado